NDC 63323-486-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-486
- Requested NDC
- 63323-486-01
- Package NDCs from labels
- 63323-486-41, 63323-486-26, 63323-486-01, 63323-486-17, 63323-486-02, 63323-486-27, 63323-486-05, 63323-486-57
- Manufacturer
- Sportpharm LLC
- Effective date
- 2026-02-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine - Sportpharm LLC | Sportpharm LLC | 2026-02-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine 2% (lidocaine HCl, injection, USP) 20mg/mL 50mL Multiple dose vial | Henry Schein, Inc. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - ASCLEMED USA INC | ASCLEMED USA INC. DBA ENOVACHEM | ASCLEMED USA INC | ASCLEMED USA INC. DBA ENOVACHEM | 2025-06-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2025-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | REMEDYREPACK INC. | 2019-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | REMEDYREPACK INC. | 2019-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| General Surgery Kit - Centurion Medical Products | APP Pharmaceuticals, LLC | Centurion Medical Products | APP Pharmaceuticals, LLC | 2013-10-02 | MEDICAL DEVICE |
| Xylocaine - Centurion Medical Products | APP Pharmaceuticals, LLC | Centurion Medical Products | APP Pharmaceuticals, LLC | 2012-03-15 | MEDICAL DEVICE |
| Xylocaine | Physicians Total Care, Inc. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-486-01 | Xylocaine | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-486-02 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-486-05 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-486-17 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-486-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-486-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-486-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-486-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 | |
| 63323-486-17 | Cardiovascular Procedure Kit | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 mL | 20 mg in 1mL | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-486 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-486 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
| 63323-486 | CARDIOVASCULAR PROCEDURE KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | Current NDC, Legacy NDC | 20120316_eed8f49f-3676-42ee-b86c-72f338818097.zip |
| 63323-486 | GENERAL SURGERY KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | Current NDC, Legacy NDC | 20140327_168ff921-70aa-45fd-80a7-6447a6d5dfe8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-486-01 | ML - Milliliter | 63323-486 | 53575e7c-ec30-491c-800d-e2f2e0aab918 | 1 | 2019-12-10 |
| 63323-486-02 | ML - Milliliter | 63323-486 | 8c00d362-7eff-4deb-bf43-53a9506aa19d | 1 | 2019-12-10 |
| 63323-486-05 | ML - Milliliter | 63323-486 | 049b2b3b-0d23-4b00-92d8-5e2643ad5117 | 1 | 2019-12-10 |
| 63323-486-17 | ML - Milliliter | 63323-486 | 06027263-d174-40ea-9f34-cde0ccedc0f0 | 1 | 2012-07-24 |
| 63323-486-26 | ML - Milliliter | 63323-486 | 348a52bc-c28e-4315-a03e-952005b530ba | 1 | 2016-09-02 |
| 63323-486-27 | ML - Milliliter | 63323-486 | a4f02f5d-1dcd-46e2-beca-2e3e86b55cf3 | 1 | 2012-07-24 |
| 63323-486-41 | ML - Milliliter | 63323-486 | cd3d5dcc-bbe6-424b-ae62-a3b6f1ecaa11 | 1 | 2025-11-13 |
| 63323-486-57 | ML - Milliliter | 63323-486 | b3d735e0-3978-4c1e-b496-40a57da89c1e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Antiseptic | ALCOHOL, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 71aeaf86-2b4d-4945-9606-a9db0ab6b726 | 2024-02-07 | Warnings | V13007Z41A |
| First Aid and Burn | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 47cb6921-5d82-4123-a9e0-0b05d4dcb5b2 | 2024-02-07 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 8eb3e7e2-26e5-430e-89aa-40a0367c637e | 2024-02-07 | Warnings | V13007Z41A |
| Lidocaine Hemorrhoid | LIDOCAINE HCL, PHENYLEPHRINE HCL, WITCH HAZEL | Walgreens Co | 10a47899-f4a0-66e8-e063-6394a90a11dd | 2024-02-05 | Warnings | EC2CNF7XFP |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 30Q7KI53AK |
| Mirakel Pain Relief Roll-On | LIDOCAINE HCL | Sanvio, Inc. | 102f3618-13ad-37e3-e063-6294a90a8086 | 2024-01-30 | Warnings | V13007Z41A |
| Natrum Muriaticum | SODIUM CHLORIDE | SEVENE USA | 11008014-fff6-4d5a-8c5c-a20443d7cc23 | 2024-01-30 | Warnings | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 8c63be55-5de4-7f72-e053-2995a90a102e | 2024-01-30 | Warnings, Adverse reactions | 1737761 V13007Z41A |
| BUPIVACAINE HCI AND EPINEPHRINE | BUPIVACAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 99516811-56e2-9c8a-e053-2a95a90ac9cb | 2024-01-30 | Warnings, Adverse reactions | 30Q7KI53AK |
| SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 946ce625-3647-5083-e053-2a95a90a1ebc | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 30Q7KI53AK |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999dd95d-87fe-12c0-e053-2995a90aa9f7 | 2024-01-30 | Warnings, Adverse reactions | 1010033 V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4bf5905-add7-1cb0-e053-2995a90a7334 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4c0df51-cc37-323d-e053-2995a90a154a | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 7a664a34-19fd-4a7b-ab4d-11299b32999e | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | fd6343a9-15a6-4894-b51f-122e4d6dbe79 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Seton Pharmaceuticals | 1c0abe84-5404-404e-b882-e910e4d43ffb | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 951862db-3a73-4d25-9d5b-e4111833f43b | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 6aa284d6-0212-4fb5-809d-c721aa6fe2ba | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | 1737761 V13007Z41A |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | 1010671 V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.